Alzheimer's Disease Is Much More Than Forgetfulness...

When most people think of Alzheimer's disease, they think of forgetfulness — misplacing keys, forgetting names, losing track of conversations. But Alzheimer's is far more than memory loss. It is a progressive, devastating neurodegenerative disease that ultimately affects every aspect of cognition, personality, and function — and it is the most common cause of dementia globally, affecting over 55 million people worldwide and an estimated 5 million in India.

What Is Alzheimer's Disease?

Alzheimer's disease is characterized by the progressive accumulation of two abnormal protein deposits in the brain: amyloid plaques (clumps of beta-amyloid protein between neurons) and neurofibrillary tangles (twisted fibers of tau protein inside neurons). These deposits disrupt neuronal communication, trigger inflammation, and ultimately cause neuronal death — leading to the progressive cognitive and functional decline that defines the disease.

Beyond Forgetfulness: The Full Spectrum of Alzheimer's

While memory loss is the most recognized symptom, Alzheimer's affects multiple cognitive domains:

• Language: Difficulty finding words, following conversations, or understanding speech
• Executive function: Impaired planning, problem-solving, and decision-making
• Visuospatial skills: Difficulty with navigation, recognizing faces, and spatial orientation
• Personality and behavior: Apathy, depression, anxiety, agitation, and personality changes are common and often more distressing for families than cognitive symptoms
• Activities of daily living: Progressive loss of ability to manage finances, drive, cook, and ultimately perform basic self-care

The Genetics of Alzheimer's Disease

Genetics plays a significant role in Alzheimer's risk. There are two distinct genetic categories:

Early-Onset Familial Alzheimer's Disease (EOFAD)

A rare form (less than 5% of cases) caused by mutations in APP, PSEN1, or PSEN2 genes. Follows autosomal dominant inheritance — a 50% chance of inheriting the mutation from an affected parent. Causes Alzheimer's typically before age 65, sometimes as early as the 30s or 40s.

Late-Onset Alzheimer's Disease

The common form, typically presenting after age 65. Has significant polygenic heritability. The most important genetic risk factor is the APOE gene. APOE4 is the strongest known genetic risk factor for late-onset Alzheimer's — carrying one copy increases risk approximately 3–4×; carrying two copies increases risk approximately 8–12×. APOE2 is protective. Genome-wide association studies have identified over 40 additional genetic loci associated with Alzheimer's risk.

Early Detection and Prevention

There is currently no cure for Alzheimer's disease, but early detection is increasingly important as disease-modifying therapies become available. Lifestyle factors that reduce Alzheimer's risk include regular aerobic exercise, cognitive engagement, social connection, Mediterranean-style diet, adequate sleep, and management of cardiovascular risk factors (hypertension, diabetes, high cholesterol).

Knowing your APOE genotype and overall genetic Alzheimer's risk allows you to prioritize these protective lifestyle factors from an early age — when they are most effective.

FAQs

Should I get tested for APOE4?

This is a personal decision that should be made with genetic counselling. APOE4 testing provides risk information but not a diagnosis — many APOE4 carriers never develop Alzheimer's. The psychological implications of knowing your APOE status should be carefully considered before testing.

Is Alzheimer's disease hereditary?

Late-onset Alzheimer's has significant genetic risk factors (particularly APOE4) but is not directly inherited in most cases. Early-onset familial Alzheimer's caused by APP, PSEN1, or PSEN2 mutations is directly inherited in an autosomal dominant pattern.